BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1064 related articles for article (PubMed ID: 28059614)

  • 1. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
    Martinez KB; Leone V; Chang EB
    Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk.
    Murphy EA; Velazquez KT; Herbert KM
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):515-20. PubMed ID: 26154278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts.
    Anhê FF; Varin TV; Le Barz M; Desjardins Y; Levy E; Roy D; Marette A
    Curr Obes Rep; 2015 Dec; 4(4):389-400. PubMed ID: 26343880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
    Brahe LK; Astrup A; Larsen LH
    Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and the development of pediatric diseases.
    Lu CY; Ni YH
    J Gastroenterol; 2015 Jul; 50(7):720-6. PubMed ID: 25917564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation.
    Martinez-Medina M; Denizot J; Dreux N; Robin F; Billard E; Bonnet R; Darfeuille-Michaud A; Barnich N
    Gut; 2014 Jan; 63(1):116-24. PubMed ID: 23598352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
    Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial contributions to chronic inflammation and metabolic disease.
    Shanahan F; Sheehan D
    Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):257-62. PubMed ID: 27097361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifts in microbiota species and fermentation products in a dietary model enriched in fat and sucrose.
    Etxeberria U; Arias N; Boqué N; Macarulla MT; Portillo MP; Milagro FI; Martinez JA
    Benef Microbes; 2015 Mar; 6(1):97-111. PubMed ID: 25213025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Interaction Between Host and the Gut Microbiota During High-Fat Diet-Induced Colorectal Cancer.
    Lee C; Lee S; Yoo W
    J Microbiol; 2024 Mar; 62(3):153-165. PubMed ID: 38625645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and metabolic diseases.
    Fukuda S; Ohno H
    Semin Immunopathol; 2014 Jan; 36(1):103-14. PubMed ID: 24196453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.